Clinical Trials
24
Active:2
Completed:16
Trial Phases
4 Phases
Phase 1:2
Phase 3:16
Phase 4:4
+1 more phases
Drug Approvals
21
PHILIPPINES:20
NMPA:1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (23 trials with phase data)• Click on a phase to view related trials
Phase 3
16 (69.6%)Phase 4
4 (17.4%)Phase 1
2 (8.7%)Not Applicable
1 (4.3%)No trials found
News
Indian Patent Office Revokes Novartis' Vymada Patent, Opening Door for Generic Competition
The Indian Patent Office revoked Novartis' patent for Vymada (Entresto), a heart failure drug generating $7.8 billion in global sales, citing lack of novelty and inventive step.